复杂腹主动脉瘤开窗腔内修复术后围手术期肌少症与长期生存的关联
这项单中心回顾性研究纳入2007至2022年因复杂腹主动脉瘤接受开窗腔内修复术(FEVAR)的169例患者,评估肌少症的纵向变化及其对结局的影响。结果显示术前肌少症患病率为20.7%,术后升至32.5%并伴显著肌肉丢失;术后新发或加重的肌少症与更差的长期生存相关,多变量分析中仅术后肌少症仍为独立预测因子(HR 1.89,95%CI 1.18-3.04;
要点
- FEVAR术后骨骼肌面积显著下降,肌少症患病率由术前20.7%升至术后32.5%。
核心结论
- FEVAR术后骨骼肌丢失显著,且与长期死亡相关,提示FEVAR存在生理负担,需重视术后评估与优化。
研究设计与样本
- 回顾性单中心研究,纳入2007至2022年因复杂腹主动脉瘤接受FEVAR的患者169例,中位年龄74.7岁,87.6%为男性,中位随访4.8年。
关键数值与推荐
- 肌少症定义采用骨骼肌面积(SMA)阈值:男性<144 cm²,女性<92 cm²,基于CT测量。
临床怎么用
- FEVAR术后应关注骨骼肌丢失,对术后新发或加重肌少症患者加强评估与优化管理。
- 术前肌少症对长期生存影响有限,术后肌肉状态变化可能更具预后价值。
局限性
- 回顾性单中心设计,样本量有限,结果需前瞻性多中心研究验证。
- 肌少症定义基于CT测量的SMA阈值,未涵盖肌肉功能评估。
- 原文未报告机制通路及干预措施对结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Sarcopenia, defined as loss of skeletal muscle mass and function, predicts adverse surgical outcomes. This study evaluated longitudinal changes in sarcopenia following fenestrated endovascular aortic repair (FEVAR) and their impact on outcomes. METHODS: This retrospective, single centre study included patients who underwent FEVAR for complex abdominal aortic aneurysms between 2007 and 2022. Sarcopenia was defined using skeletal muscle area (SMA) cutoffs of < 144 cm2 for men and < 92 cm2 for women, measured from computed tomography scans. The primary outcome was all cause death; secondary outcomes included longitudinal changes in SMA, analysed with mixed effects models. RESULTS: The study included 169 patients (median age 74.7 years; 87.6% men) with median follow up of 4.8 years. The pre-operative sarcopenia prevalence was 20.7% (n = 35), which increased to 32.5% (n = 55) post-operatively, with significant muscle loss (-6.6 ± 7.2%; p < .001). Subsequently, sarcopenia rates gradually declined to ∼27% over 3 years (1 year: -3.3 ± 9.2%, p < .001; 2 years: -3.7 ± 8.4%, p < .001; 3 years: -3.8 ± 10.7%, p = .006). Pre-operative sarcopenia did not impact 30 day outcomes or overall survival compared with non-sarcopenic patients at these time points (1 year: 88.4% vs. 95.2%; 3 years: 76.7% vs. 78.6%; 5 years: 55.8% vs. 61.9%, p = .090). Conversely, new or worsened post-FEVAR sarcopenia was associated with poorer survival (1 year: 90.6% vs. 95.2%; 3 years: 73.4% vs. 81.0%; 5 years: 53.1% vs. 64.8%; 7 years: 25.5% vs. 47.4%; 10 years: 2.1% vs. 15.5%, p = .001). Post-operative sarcopenia was a stronger predictor of overall mortality (hazard ratio [HR] 2.00, 95% confidence interval [CI] 1.30 - 3.10; p = .002) compared with pre-operative sarcopenia (HR 1.76, 95% CI 1.06 - 2.93; p = .030). In multivariable analysis, only post-operative sarcopenia remained significant (HR 1.89, 95% CI 1.18 - 3.04; p = .009) and was associated with higher seven (74.5% vs. 52.6%; p = .020) and ten year mortality rates (97.9% vs. 84.5%; p = .035). CONCLUSION: In this retrospective observational study, post-operative skeletal muscle loss following FEVAR was significant and was associated with long term death. This suggests that FEVAR carries a physiological burden warranting careful post-operative assessment and optimisation. Prospective multicentre studies are needed to establish mechanistic pathways and to determine whether interventions improve outcomes.
引用
- El-Sayed T, Sivaharan A, Ugwumba L, et al. Association between Peri-operative Sarcopenia and Long Term Survival following Fenestrated Endovascular Aortic Repair for Complex Abdominal Aortic Aneurysm. Eur J Vasc Endovasc Surg. 2026. PMID: 42336096. doi:10.1016/j.ejvs.2026.06.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。